Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03780205 · ClinicalTrials.gov registry record
Bilateral and Unilateral Amblyopia Treatment Study
A clinical trial, sponsored by Salus University.
- Terminated
- Registry status
- 1
- Enrollment target
NCT03780205 is a clinical trial that was terminated before completion, run by Salus University. The registered enrollment target is 1 participants.
The verdict
NCT03780205 was terminated before completion, sponsored by Salus University.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The purpose for this study is to investigate spectacle compliance and treatment outcome in bilateral and unilateral refractive amblyopia in children age 3 to \<10 years old. Specifically, how frequently and for what duration is spectacle wear necessary to maximize best-corrected visual acuity by spectacle correction alone.
Interventions
- OTHER Prescription glasses for bilateral amblyopia
- OTHER Prescription glasses for unilateral amblyopia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-03-20 |
| Est. Completion | 2020-07-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03780205
The ClinicalTrials.gov registry entry for NCT03780205 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Salus University, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prescription glasses for bilateral amblyopia is the first listed.
NCT03780205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03780205 about?
NCT03780205 is a clinical study titled "Bilateral and Unilateral Amblyopia Treatment Study". The purpose for this study is to investigate spectacle compliance and treatment outcome in bilateral and unilateral refractive amblyopia in children age 3 to \<10 years old. Specifically, how frequently and for what duration is spectacle wear necessary to maximize best-corrected visual acuity by spe...
What is the current status of trial NCT03780205?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2019-03-20. Estimated completion is 2020-07-07.
What interventions are being tested in trial NCT03780205?
The interventions under investigation include: Prescription glasses for bilateral amblyopia (OTHER), Prescription glasses for unilateral amblyopia (OTHER).
Who is sponsoring clinical trial NCT03780205?
This trial is sponsored by Salus University, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.